Aquestive Therapeutic
AQST3.6004.26% ( -0.160 )
Aquestive Therapeutic (AQST)
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulati...
- Open
- 3.760
- High
- 3.780
- Low
- 3.560
- Prev. Close
- 3.760
- Volume
- 2.58M
- Turnover
- 9.43M
- Avg Price
- 3.648
- Bid/Ask Ratio
- --
- Amplitude
- 5.85%
- 52wk High
- 7.550
- Volume Ratio
- 1.26
- Turnover Ratio
- 2.26%
Aquestive Therapeutic Analyst Rating
View MoreForecast & Rating
Jun 25, 2026Price forecast
$8.89146.91%
Forecast & RatingStrong buy
9analysts
- Strong buy77.78%
- Buy22.22%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 17 at 12:16 PM
Aquestive Therapeutics CEO Daniel Barber disposes of 25,000 common shares worth $100,201.97
- Tip Ranks · Jun 25 at 11:55 AM
BTIG’s Brisebois Reiterates Buy on Aquestive Therapeutics, Calling Sell-Off Overdone After SPRY Payer Update and Highlighting Limited Scope of FDA CRL for Anaphylm
- PUBT · Jun 24 at 10:12 AM
Aquestive Therapeutics director Julie Krop disposes of 25,000 common shares for $125,392.5
- Tip Ranks · May 15 at 07:01 AM
Aquestive Therapeutics (AQST) Receives a Buy from Oppenheimer
- benzinga_article · May 14 at 08:09 AM
Aquestive Therapeutics Q1 2026 Earnings Call: Complete Transcript
- benzinga_article · May 13 at 04:06 PM
12 Health Care Stocks Moving In Wednesday's After-Market Session
